Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients

被引:20
作者
Bergsland, KJ [1 ]
Kinder, JM
Asplin, JR
Coe, BJ
Coe, FL
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] LithoLink Corp, Chicago, IL USA
关键词
kidney calculi; calcium oxalate; crystallization; inhibitors;
D O I
10.1016/S0022-5347(05)64987-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We define the relationships between urine inhibition of calcium oxalate crystal growth and age, gender, urine chemistries and stone formation among relatives of calcium stone forming patients. Materials and Methods: We collected 24-hour urine samples from 366 first degree relatives of calcium stone formers. Calcium oxalate crystal growth inhibition was studied using a constant amount of dialyzed urine protein in a seeded crystallization system. Standard stone risk measurements were also performed on the urine, including supersaturation for calcium oxalate, calcium phosphate and uric acid. Results: By multivariate analysis crystal growth inhibition is strongly inversely related to the amount of protein excreted per day, and the age of the subject. When corrected for protein excretion and age, urine proteins from nonstone forming male subjects inhibited crystal growth more strongly than those from corresponding female subjects. Among stone formers the sex difference was not present. Conclusions: Inhibition of calcium oxalate crystal growth is influenced by a complex combination of gender, age, stone formation and assay conditions. The effect of daily protein excretion is most likely a consequence of using a fixed amount of urine protein per assay. The influence of age is significant and unexplained, with the urine of young people (less than 20 years) demonstrating a vigorous ability to inhibit crystallization. In addition, the urine of nonstone forming male relatives appears to have a greater ability to inhibit crystallization than that of nonstone forming female relatives. Further use of this assay in clinical investigations must take age and gender into proper account.
引用
收藏
页码:2372 / 2376
页数:5
相关论文
共 24 条
[1]   Supersaturation and stone composition in a network of dispersed treatment sites [J].
Asplin, J ;
Parks, J ;
Lingeman, J ;
Kahnoski, R ;
Mardis, H ;
Lacey, S ;
Goldfarb, D ;
Grasso, M ;
Coe, F .
JOURNAL OF UROLOGY, 1998, 159 (06) :1821-1825
[2]   Contribution of human uropontin to inhibition of calcium oxalate crystallization [J].
Asplin, JR ;
Arsenault, D ;
Parks, JH ;
Coe, FL ;
Hoyer, JR .
KIDNEY INTERNATIONAL, 1998, 53 (01) :194-199
[3]   Reduced crystallization inhibition by urine from men with nephrolithiasis [J].
Asplin, JR ;
Parks, JH ;
Chen, MS ;
Lieske, JC ;
Toback, FG ;
Pillay, SN ;
Nakagawa, Y ;
Coe, FL .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1505-1516
[4]   Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-alpha-inhibitor [J].
Atmani, F ;
Mizon, J ;
Khan, SR .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (03) :984-990
[5]   Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers [J].
Borghi, L ;
Guerra, A ;
Meschi, T ;
Briganti, A ;
Schianchi, T ;
Allegri, F ;
Novarini, A .
KIDNEY INTERNATIONAL, 1999, 55 (03) :1041-1050
[6]   STONE FORMATION IN GENETIC HYPERCALCIURIC RATS [J].
BUSHINSKY, DA ;
GRYNPAS, MD ;
NILSSON, EL ;
NAKAGAWA, Y ;
COE, FL .
KIDNEY INTERNATIONAL, 1995, 48 (06) :1705-1713
[7]  
COE FL, 1980, MINER ELECTROL METAB, V3, P268
[8]   FAMILIAL IDIOPATHIC HYPERCALCIURIA [J].
COE, FL ;
PARKS, JH ;
MOORE, ES .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (07) :337-340
[9]   Urinary kidney stone inhibitors. What is the news? [J].
Dussol, B ;
Berland, Y .
UROLOGIA INTERNATIONALIS, 1998, 60 (02) :69-73
[10]   Urinary calcium oxalate saturation in healthy infants and children [J].
Hoppe, B ;
Jahnen, A ;
Bach, D ;
Hesse, A .
JOURNAL OF UROLOGY, 1997, 158 (02) :557-559